The medtronic intact bioprosthesis: Clinical and hemodynamic performance over 13 years

Artificial Organs

Volumn 26, Issue 10, 2002, Pages 851-855

  De la Fuente, Anselmo ^a   Sánchez, José Ramón ^a   Fernández, Juan Luis ^a   Romero, Javier ^a   Berjon, Jesús ^a   Moriones, Ignacio ^a  

^a Universidad Pública de Navarra   (Spain)

Author keywords

Aortic Valve; Bioprosthesis; Medtronic Intact; Replacement

Indexed keywords

BLOOD VESSELS;

AORTIC POSITION; AORTIC VALVES; BIOPROSTHESES; FOLLOW UP; HAEMODYNAMICS; MEDTRONIC INTACT; MORTALITY RATE; PERFORMANCE; REPLACEMENT; VALVE REPLACEMENT;

DETERIORATION;

ADULT; AGED; AORTA PROSTHESIS; AORTA VALVE DISEASE; AORTA VALVE REPLACEMENT; ARTICLE; BIOPROSTHESIS; BLEEDING; CONTROLLED STUDY; DEVICE; ENDOCARDITIS; FOLLOW UP; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROSTHESIS FAILURE; REOPERATION; SURGICAL MORTALITY; SURVIVAL TIME; THROMBOEMBOLISM;

EID: 0036906741     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1594.2002.06984.x     Document Type: Article

References (20)

1. Grunkemeier GL, Starr A, Rahimtoola SH. Prosthetic heart valve performance: Long term follow-up. In: O'Rourke RA, McCall D, eds. Current Problems in Cardiology. St. Louis: Mosby Year-Book, 1992:329-406.
2. Casselman FP, Bots ML, Lommel WV, Knaepen PJ, Lensen R, Vermeulen FEE. Repeat thromboembolic and bleeding events after mechanical aortic valve replacement. Ann Thorac Surg 2001;71:1172-80.
3. Edmunds LH Jr, Clark RE, Cohn LH, Grunkemeier GL, Miller DG, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac operations. Ann Thorac Surg 1996; 62:932-35.
4. Barratt-Boyes BG, Ko PH, Jaffe WM. The zero pressure fixed Medtronic Intact porcine valve: Clinical results over six year period, including serial echocardiographic assessment. J Cardiac Surg 1991;6(Suppl 4):606-12.
5. Barratt-Boyes BG. Clinical experience with the zero-pressure fixed Medtronic Intact bioprosthetic valve. Eur J Cardiothorac Surg 1992;6(Suppl I):S79-81.
6. Barratt-Boyes BG, Jaffe WM, Ko PH, Whitlock RM. The zero pressure fixed Medtronic Intact porcine valve: An 8.5 year review. J Heart Valve Dis 1993;2:604-11.
7. Jaffe WM, Barratt-Boyes BG, Sadri A, Gavin JB, Coverdale HA, Neutze JM. Early follow up of patients with Medtronic Intact porcine valve. A new cardiac bioprothesis. J Thorac Cardiovasc Surg 1989;98:181-92.
8. Mullany CJ, Schaff HV, Orszulak TA, Miller FA. Early clinical and hemodynamic evaluation of the aortic intact porcine bioprosthesis. J Heart Valve Dis 1994;3:641-7.
9. Munro AI, Jamieson RE, Frank G, Tyers O, Burr LH. The Medtronic Intact bioprosthesis: Clinical performance to eight years. J Heart Valve Dis 1994;3:634-40.
10. Barratt-Boyes BG, Jaffe WM, Whitlock RM. The Medtronic Intact porcine valve: Ten-year clinical review. J Thorac Cardiovasc Surg 1998;116:1005-14.
11. Jamieson WRE, Lemieux MD, Sullivan JA, Munro AI, Métras J, Cartier PC. Medtronic Intact porcine bioprosthesis: 10 Years' experience. Ann Thorac Surg 1998;66(Suppl 6): Sl18-21.
12. Broom N, Thomson EJ. Influence of fixation condition on performance of glutaraldehyde-treated porcine aortic valves: Towards a more scientific basis. Thorax 1979;34:166-76.
13. Mayne ASD, Christie GW, Smaill BH, Hunger PJ, BarrattBoyes BG. An assessment of the mechanical properties of leaflets from four second generation porcine bioprostheses with biaxial testing techniques. J Thorac Cardiovasc Surg 1989;98:170-80.
14. Vesely I. Analysis of Medtronic Intact bioprosthetic valve: Effects of "zero-pressure" fixation. J Thorac Cardiovasc Surg 1991;101:90-9.
15. Flomenbaum MA, Schoen FJ. Effects of fixation back pressure and antimineralization treatment on the morphology of porcine aortic bioprosthetic valves. J Thorac Cardiovasc Surg 1993;105:154-64.
16. Lentz D J, Pollock EM, Olsen DB, Andrews E J, Murashita J, Hartrip WL. Inhibition of mineralization of glutaraldehydefixed Hancock bioprosthetic heart valves. In: Cohn LH, Galluci V, eds. Cardiac Bioprostheses. New York: Yorke, 1982: 306-19.
17. Jones M, Eidbo EE, Hilbert SL, Ferrano V J, Clark RE. Anticalcification treatments of bioprosthetic heart valves. In vivo, studies in sheep. V Cardiac Surg 1989;4:69-73.
18. Jaffe WM, Coverdale HA, Roch AH, Whitlock RM, Neutze JM, Barratt-Boyes BG. Rest and exercise hemodynamics of 20 to 23 mm allograft, Medtronic Intact (porcine), and St Jude Medical valves in the aortic position. J Thorac Cardiovasc Surg 1990;100:167-74.
19. Kadir I, Izzat MB, Wilde P, Reeves B, Bryan AJ, Angelini GD. Dynamic evaluation of the 21 mm Medtronic Intact aortic bioprosthesis by dobutamine echocardiography. Ann Thorac Surg 1997;63:1128-32.
20. Strike PC, Balanescu A, Gardiner D, Livesey SA, Simpson IA. Rest and exercise Doppler hemodynamics of the Medtronic Intact bioprosthesis. J Heart Valve Dis 1999;8: 530-5.